Joel Isaacson & Co., LLC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 121 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.18 and the average weighting 0.4%.

Quarter-by-quarter ownership
Joel Isaacson & Co., LLC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$57,000
+42.5%
9,0000.0%0.01%
+37.5%
Q3 2016$40,000
+53.8%
9,0000.0%0.01%
+33.3%
Q2 2016$26,000
+4.0%
9,0000.0%0.01%0.0%
Q1 2016$25,000
-73.1%
9,0000.0%0.01%
-73.9%
Q4 2015$93,000
-9.7%
9,0000.0%0.02%
-14.8%
Q3 2015$103,000
-42.5%
9,000
-25.0%
0.03%
-41.3%
Q2 2015$179,000
+65.7%
12,0000.0%0.05%
+70.4%
Q1 2015$108,000
-26.0%
12,0000.0%0.03%
-30.8%
Q4 2014$146,000
+24.8%
12,0000.0%0.04%
+8.3%
Q3 2014$117,000
-23.5%
12,0000.0%0.04%
-25.0%
Q2 2014$153,000
+20.5%
12,0000.0%0.05%
+11.6%
Q1 2014$127,000
+39.6%
12,0000.0%0.04%
+30.3%
Q4 2013$91,000
+4.6%
12,0000.0%0.03%
-8.3%
Q3 2013$87,000
+357.9%
12,0000.0%0.04%
+300.0%
Q2 2013$19,000
+35.7%
12,0000.0%0.01%
+28.6%
Q1 2013$14,000
-17.6%
12,0000.0%0.01%
-36.4%
Q4 2012$17,00012,0000.01%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
VHCP Management, LLC 1,744,356$18,455,0009.59%
RA Capital Management 4,347,456$45,996,0003.30%
Cormorant Asset Management, LP 1,168,000$12,357,0002.84%
Baker Brothers Advisors 5,867,031$62,073,0000.79%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 907,920$9,606,0000.39%
QVT Financial LP 525,734$5,562,0000.32%
EAM Investors, LLC 114,548$1,212,0000.22%
FRANKLIN STREET ADVISORS INC /NC 93,000$984,0000.20%
THB ASSET MANAGEMENT 301,529$3,190,0000.19%
TPG Group Holdings (SBS) Advisors, Inc. 1,162,269$12,297,0000.13%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders